-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Ambrx Biopharma, Inc. quarterly Revenues history and growth rate from Q3 2022 to Q3 2023.
- Ambrx Biopharma, Inc. Revenues for the quarter ending September 30, 2023 was $53K, a 96.7% decline year-over-year.